Refine Your Results

Click below to filter your search results

Search Results

Return to List
Results 201–220 of 231
Title Date
201.

Surrogate Motherhood

Number 397

ABSTRACT: Ethical responsibilities are described for obstetrician–gynecologists who choose to participate in surrogacy arrangements by 1) advising couples who are considering surrogacy, 2) counseling potential surrogate mothers, 3) providing obstetric services for pregnant women participating in s...

February 2008

PDF Format
202.

Tamoxifen and Uterine Cancer

Number 601

(Replaces Committee Opinion Number 336, June 2006)

ABSTRACT: Tamoxifen, a nonsteroidal antiestrogen agent, is widely used as adjunctive therapy for women with breast cancer, and it has been approved by the U.S. Food and Drug Administration for adjuvant treatment of breast cancer, treatment of metastatic breast cancer, and reduction in breast cance...

June 2014

PDF Format
203.

The Apgar Score

Number 333

(Reaffirmed 2010, Replaces No. 174, July 1996)

ABSTRACT: The Apgar score provides a convenient shorthand for reporting the status of the newborn infant and the response to resuscitation. The Apgar score has been used inappropriately to predict specific neurologic outcome in the term infant. There are no consistent data on the significance of t...

May 2006

PDF Format
204.

The Importance of Preconception Care in the Continuum of Women's Health Care

Number 313

(Reaffirmed 2012)

ABSTRACT: The goal of preconception care is to reduce the risk of adverse health effects for the woman, fetus, or neonate by optimizing the woman's health and knowledge before planning and conceiving a pregnancy. Because reproductive capacity spans almost four decades for most women, optimizing wo...

September 2005

PDF Format
205.

The Initial Reproductive Health Visit

Number 598

(Replaces Committee Opinion Number 460, July 2010)

Abstract: The initial visit for screening and the provision of reproductive preventive health care services and guidance should take place between the ages of 13 years and 15 years. The initial reproductive health visit provides an excellent opportunity for the obstetrician–gynecologist to start a...

May 2014

PDF Format
206.

The Limits of Conscientious Refusal in Reproductive Medicine

Number 385

(Reaffirmed 2013)

ABSTRACT: Health care providers occasionally may find that providing indicated, even standard, care would present for them a personal moral problem—a conflict of conscience—particularly in the field of reproductive medicine. Although respect for conscience is important, conscientious refusals shou...

November 2007

PDF Format
207.

The Obstetric-Gynecologic Hospitalist

Number 459

(Reaffirmed 2012)

ABSTRACT: The work models for the obstetric–gynecologic hospitalist and the obstetric laborist are gaining popularity and momentum in hospitals across the nation. These models could be timely solutions to the challenging demands of the general practice of obstetrics and gynecology. The American Co...

July 2010

PDF Format
208.

The Role of Cystourethroscopy in the Generalist Obstetrician-Gynecologist Practice

Number 372

(Reaffirmed 2013)

ABSTRACT: Cystourethroscopy can be performed for diagnostic and a few operative indications by obstetrician–gynecologists to help improve patient care. Perhaps the most important indications for cystourethroscopy are to rule out cystotomy and intravesical or intraurethral suture or mesh placement ...

July 2007

PDF Format
209.

The Role of the Obstetrician Gynecologist in the Early Detection of Epithelial Ovarian Cancer

Number 477

(Replaces No. 280, December 2002)

ABSTRACT: Epithelial ovarian cancer is most commonly detected in an advanced stage, when the overall 5-year survival rate is 20–30%. Detection of early-stage ovarian cancer results in improved survival. Currently, there is no effective strategy for ovarian cancer screening. Women with persistent a...

March 2011

PDF Format
210.

The Role of Transvaginal Ultrasonography in the Evaluation of Postmenopausal Bleeding

Number 440

(Reaffirmed 2013)

ABSTRACT: The clinical approach to postmenopausal bleeding requires prompt and efficient evaluation to exclude or diagnose carcinoma. Women with postmenopausal bleeding may be assessed initially with either endometrial biopsy or transvaginal ultrasonography; this initial evaluation does not requir...

August 2009

PDF Format
211.

The Uninsured

Number 416

(Replaces No. 308, December 2004)

ABSTRACT: The United States is one of the few industrialized nations in the world that do not guarantee health care for their populations. Access to health care for all women is of paramount concern to obstetrician–gynecologists and the American College of Obstetricians and Gynecologists. Pregnant...

September 2008

PDF Format
212.

The Use of Chromosomal Microarray Analysis in Prenatal Diagnosis

Number 581

(Replaces No. 446, November 2009) (See also Practice Bulletin No. 88)

ABSTRACT: Chromosomal microarray analysis is a technique that identifies chromosomal abnormalities, including submicroscopic abnormalities that are too small to be detected by conventional karyotyping. Like conventional fetal karyotyping, prenatal chromosomal microarray analysis requires direct te...

December 2013

PDF Format
213.

Timing of Umbilical Cord Clamping After Birth

Number 543

ABSTRACT: The optimal timing for clamping the umbilical cord after birth has been a subject of controversy and debate. Although many randomized controlled trials in term and preterm infants have evaluated the benefits of delayed umbilical cord clamping versus immediate umbilical cord clamping, the...

December 2012

PDF Format
214.

Tobacco Use and Women's Health

Number 503

(Reaffirmed 2013)

ABSTRACT: Tobacco use negatively affects every organ system and is the most prevalent cause of premature death for adults within the United States. Compared with women who are nonsmokers, women who smoke cigarettes have greater risks of reproductive health problems, many forms of gynecologic cance...

September 2011

PDF Format
215.

Tracking and Reminder Systems

Number 546

(Replaces No. 461, August 2010)

ABSTRACT: An accurate and effective tracking or reminder system is useful for the modern practice of obstetrics and gynecology. Practices should not rely solely on the patient to complete all ordered studies and to follow up on health care provider recommendations. Health care providers should enc...

December 2012

PDF Format
216.

Tubal Ligation with Cesarean Delivery

Number 205

Tubal ligation at the time of cesarean delivery requires significant additional physician work even though the technical work of the procedure is brief. Informed consent by the patient requires considerably more counseling by the physician regarding potential risks and benefits of this procedure t...

August 1998

PDF Format
217.

Umbilical Cord Blood Banking

Number 399

(Reaffirmed 2012, Replaces No. 183, April 1997)

ABSTRACT: Two types of banks have emerged for the collection and storage of umbilical cord blood—public banks and private banks. Public banks promote allogenic (related or unrelated) donation, analogous to the current collection of whole blood units in the United States. Private banks were initial...

February 2008

PDF Format
218.

Umbilical Cord Blood Gas and Acid-Base Analysis

Number 348

(Reaffirmed 2012)

ABSTRACT: Umbilical cord blood gas and acid-base assessment are the most objective determinations of the fetal metabolic condition at the moment of birth. Moderate and severe newborn encephalopathy, respiratory complications, and composite complication scores increase with an umbilical arterial ba...

November 2006

PDF Format
219.

Understanding and Using the U.S. Selected Practice Recommendations for Contraceptive Use, 2013

Number 577

ABSTRACT: The U.S. Selected Practice Recommendations for Contraceptive Use, 2013 (U.S. SPR), issued by the Centers for Disease Control and Prevention is a companion piece to the Centers for Disease Control and Prevention’s U.S. Medical Eligibility Criteria for Contraceptive Use, 2010. The U.S. Med...

November 2013

PDF Format
220.

Understanding and Using the US Medical Eligibility Criteria for Contraceptive Use, 2010

Number 505

(Reaffirmed 2014)

ABSTRACT: The 2010 U.S. Medical Eligibility Criteria for Contraceptive Use (U.S. MEC) issued by the Centers for Disease Control and Prevention gives comprehensive, evidence-based guidance to clinicians providing family planning services to women, especially women with medical conditions. The Ameri...

September 2011

PDF Format